Massive Bio, Inc. — Form D
Massive Bio, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-02. The offering totals $5.5M, of which $2.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-05-02
- Form: D
- Accession: 0001193805-19-000434
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $2.5M
- Remaining: $3.0M
- Minimum investment: $500K
- Investors: 2
- Date of first sale: 2019-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-338702
Issuer
- Name: Massive Bio, Inc.
- CIK: 0001775507
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 90 WEST ST., NEW YORK, NY, 10006
- Phone: +1-734-262-1020
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Arturo Loaiza-Bonilla | Director | Philadelphia, PA |
| Selin Kurnaz | Executive Officer | New York, NY |
More